Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib.
Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D.
Rothstein B, et al. Among authors: huang v.
J Am Acad Dermatol. 2017 Jun;76(6):1054-1060.e1. doi: 10.1016/j.jaad.2017.02.049. Epub 2017 Apr 5.
J Am Acad Dermatol. 2017.
PMID: 28390737